Purple Biotech Ltd logo

Purple Biotech Ltd - ADR

NEW
NAS:PPBT (Israel)   ADR
$ 1.68 -0.010 (-0.59%) 10:08 PM EST
At Loss
P/B:
0.67
Market Cap:
$ 6.25M
Enterprise V:
$ -54.00K
Volume:
45.69K
Avg Vol (2M):
431.12K
Trade In:
Volume:
45.69K
At Loss
Avg Vol (2M):
431.12K

Business Description

Description
Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.
Name Current Vs Industry Vs History
Cash-To-Debt
34.95
Equity-to-Asset
0.67
Debt-to-Equity
0.02
Debt-to-EBITDA
-0.01
Piotroski F-Score
2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
27.27
9-Day RSI
26.96
14-Day RSI
28.29
3-1 Month Momentum %
-27.32
6-1 Month Momentum %
-58.91
12-1 Month Momentum %
-87.55

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
1.48
Quick Ratio
1.48
Cash Ratio
1.4

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-115.9
Shareholder Yield %
-46.55

Profitability Rank

Name Current Vs Industry Vs History
ROE %
-111.33
ROA %
-92.25
ROIC %
-35.1
3-Year ROIIC %
-163.73
ROC (Joel Greenblatt) %
-8524.83
ROCE %
-110.76
Moat Score
4
Tariff Resilience Score
5
Name Current Vs Industry Vs History
PB Ratio
0.67
EV-to-Forward-Revenue
1.7
EV-to-FCF
0.01
FCF Yield %
-108.07

GF Valueâ„¢

Purple Biotech Ltd Filings

Filing Date Document Date Form
No Filing Data

Purple Biotech Ltd Stock Events

Financials Calendars
Event Date Price ($)
Third quarter earnings results for 2026 2026-11-13 In 137 days
Second quarter earnings results for 2026 2026-08-06 In 38 days
General meeting for 2026 2026-06-26 16:30 1.75 (+0.57%)
First quarter earnings results for 2026 2026-05-15 3.69 (-6.95%)
Annual report for 2025 2026-03-19 3.81 (-4.75%)
Fourth quarter earnings results for 2025 2026-03-13 3.84 (-4.00%)
0.1:1 Stock Split 2026-03-02 4.42 (-7.83%)
Third quarter earnings results for 2025 2025-11-14 7.40 (-3.87%)
Second quarter earnings results for 2025 2025-08-06 22.60 (+3.43%)
First quarter earnings results for 2025 2025-05-21 24.10 (+4.78%)
Show
Entries

Guru Commentaries on NAS:PPBT

No articles.

Articles on Purple Biotech Ltd

No articles.

Headlines

See More
  • 1
No news.
  • 1